Department of the Army, DoD.
In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 60/653,230 entitled “Development of a Biosensor for Anthrax Therapeutics and Diagnostics, filed February 14, 2005. The United States Government, as represented by the Secretary of the Army, has rights in this invention.
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-ZA-J, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.End Further Info End Preamble Start Supplemental Information
This biosensor can be used for several different purposes namely: (1) Study toxin protein-protein interactions; (2) Screen anthrax therapeutic molecules such as antibodies and small molecules; (3) As a diagnostic tool to detect anthrax toxins in blood or urine samples.Start Signature
Brenda S. Bowen
Army Federal Register Liaison Officer.
[FR Doc. 05-12308 Filed 6-21-05; 8:45 am]
BILLING CODE 3710-08-M